ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,580Medicare Part D Prescriptions Filled, Including Refills

Rank: 225 out of 2588

$790K Total Retail Price of All Prescriptions

Rank: 162 out of 2588

329 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

38% of this provider’s 329 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 9,747 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 760 643 1 1
METFORMIN HCL 626 458 2 8
DICLOFENAC SODIUM 494 404 3 124
OMEPRAZOLE 423 308 4 6
DIOVAN 387 335 5 29
HYDROCODONE-ACETAMINOPHEN 365 218 S3 6 7
LEVOTHYROXINE SODIUM 363 314 7 2
AMLODIPINE BESYLATE-BENAZEPRIL 333 248 8 76
METOPROLOL SUCCINATE 283 263 9 12
LOVAZA 214 159 10 119
NEXIUM 193 164 11 41
CRESTOR 188 141 12 25
PAROXETINE HCL 177 135 13 71
ZOLPIDEM TARTRATE 170 116 14 24
FUROSEMIDE 169 144 15 5
ALENDRONATE SODIUM 166 161 16 21
ACTOS 159 119 17 105
SINGULAIR 153 119 18 94
BENAZEPRIL HCL 144 90 19 84
JANUVIA 144 140 19 60
TAMSULOSIN HCL 142 120 21 23
ACETAMINOPHEN-CODEINE 136 113 S3 22 80
AMLODIPINE BESYLATE 134 98 23 4
LANTUS 121 67 24 47
ACTONEL 119 109 25 184
AZITHROMYCIN 111 88 26 45
CLOTRIMAZOLE-BETAMETHASONE 109 96 27 155
ATORVASTATIN CALCIUM 108 84 28 11
WARFARIN SODIUM 100 81 29 10
ADVAIR DISKUS 98 71 30 48
HYDROCHLOROTHIAZIDE 96 80 31 13
IBUPROFEN 96 47 31 62
LEVOFLOXACIN 94 80 33 77
LYRICA 94 56 33 100
LANSOPRAZOLE 91 75 35 157
DIOVAN HCT 87 70 36 72
PLAVIX 86 66 37 43
DONEPEZIL HCL 86 86 37 22
PANTOPRAZOLE SODIUM 85 75 39 28
PREDNISONE 78 57 40 42
ENALAPRIL MALEATE 77 43 41 31
CLOPIDOGREL 72 62 42 30
METOCLOPRAMIDE HCL 72 57 42 136
FEXOFENADINE HCL 68 63 44 319
METOPROLOL TARTRATE 67 39 45 9
POTASSIUM CHLORIDE 67 51 45 15
MECLIZINE HCL 66 55 47 120
CIPROFLOXACIN HCL 65 53 48 82
LOSARTAN POTASSIUM 62 55 49 17
NOVOLOG MIX 70-30 60 53 50 271
FENOFIBRATE 60 50 50 64
MONTELUKAST SODIUM 58 44 52 153
ZETIA 58 29 52 69
PROAIR HFA 58 50 52 50
FLUTICASONE PROPIONATE 57 52 55 40
LISINOPRIL 57 42 55 3
GABAPENTIN 57 39 55 18
CYCLOBENZAPRINE HCL 57 32 R 55 87
FAMOTIDINE 57 43 55 36
ACTOPLUS MET 56 56 60 495
LEVEMIR FLEXPEN 56 15 60 220
MUPIROCIN 55 51 62 235
COMBIVENT 55 54 62 145
TRIAMCINOLONE ACETONIDE 54 49 64 106
NASONEX 52 36 65 218
VERAPAMIL ER 52 47 65 102
NIFEDIPINE ER 50 48 67 59
CEPHALEXIN 50 44 67 138
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 21, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.